Tumour biology, metastatic sites and taxanes sensitivity as determinants of eribulin mesylate efficacy in breast cancer: results from the ERIBEX retrospective, international, multicenter study.

BMC Cancer · 2015 · PMC4599752 · PMID 26449988

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

of borderline significancep = 0.052so close (0.05 < p ≤ 0.1)

Using a logistic regression analysis, HER2 positivity was significantly associated with higher CBR (HR = 0.38, p = 0.02); the presence of serous metastases was of borderline significance (HR = 0.55, p = 0.052), while a TN status and the presence of lung metastases were significantly associated with lower CBR rates (HR = 2.04, p = 0.044 and HR = 2.16 and p = 0.006, respectively).

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.